OM
LRMR icon

Opaleye Management’s Larimar Therapeutics LRMR Stock Holding History

Opaleye Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,720,867
Closed -$10.6M – 59
2025
Q3 		$10.6M Sell
3,720,867
-389,133
-9% -$1.46M 1.49% 16
2025
Q2 		$11.9M Buy
4,110,000
+2,195,923
+115% +$5.08M 2.4% 11
2025
Q1 		$4.12M Buy
+1,914,077
New +$6.05M 0.92% 24
2024
Q2 		– Sell
-174,413
Closed -$1.32M – 56
2024
Q1 		$1.32M Sell
174,413
-449,087
-72% -$3.5M 0.29% 44
2023
Q4 		$2.84M Sell
623,500
-225,000
-27% -$759K 0.75% 32
2023
Q3 		$3.35M Sell
848,500
-541,500
-39% -$2.05M 1.09% 26
2023
Q2 		$4.35M Sell
1,390,000
-11,000
-0.8% -$44.9K 1.04% 25
2023
Q1 		$6.35M Sell
1,401,000
-159,000
-10% -$831K 1.9% 15
2022
Q4 		$6.44M Sell
1,560,000
-101,784
-6% -$347K 2.24% 13
2022
Q3 		$5.32M Buy
1,661,784
+728,970
+78% +$1.83M 2.2% 14
2022
Q2 		$1.83M Sell
932,814
-10,888
-1% -$32.2K 0.82% 31
2022
Q1 		$3.82M Buy
943,702
+60,100
+7% +$393K 1.19% 23
2021
Q4 		$9.53M Buy
883,602
+50,795
+6% +$565K 2.02% 18
2021
Q3 		$9.6M Buy
832,807
+105,007
+14% +$1.26M 1.79% 19
2021
Q2 		$7.15M Buy
+727,800
New +$8.22M 1.19% 27

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Opaleye Management's LRMR Position: Q4 2025 in Review

Opaleye Management sold out of Larimar Therapeutics (LRMR) in Q4 2025, closing a stake of 3,720,867 shares — an estimated $10.6M sold.

Opaleye Management first reported a position in LRMR in Q2 2021 and held it in 15 quarters. The position peaked at $11.9M in Q2 2025. 136 funds tracked by Wall St. Rank hold LRMR as of Q4 2025.

  • Opaleye Management reported no remaining Larimar Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Opaleye Management sold 3,720,867 Larimar Therapeutics shares in Q4 2025, an estimated $10.6M.
  • Opaleye Management first reported a position in Larimar Therapeutics in Q2 2021 and held it in 15 quarters.
  • Opaleye Management's Larimar Therapeutics position peaked at $11.9M in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2025.

Based on Opaleye Management's 13F filing for Q4 2025, filed 17 Feb 2026.